4Simon TL,Snyder EL,Solheim BG et al. Rossi's principles of trans- fusion medicine. 4th ed. West Sussex: Blackwell Publishing Ltd, 2009 :vi-vii.
5World Health Organization. The clinical use of blood in medicine, obstetrics, paediatrics, surgery and anaesthesia, trauma and bums. Geneva: Malta ,2001 : 126 -152.
2ISBT Working Party on Haemovigilance. Proposed standard defini- tions for surveillance of non infectious adverse transfusion reac- tions. 2011-07 [ 2012-06-09 ]. http ://www. ihn-org, com/wp-con- tent/uploads/2011/06/ISBT-definitions-for-non-infectious-transfu- sion-reactions, pdf.
3WHO. WHO draft guidelines for adverse event reporting and learn- ing systems. WHO Document Production Services, Geneva, Switz- erland, 2005, 10.
4卫生部.医疗机构临床用血管理办法(卫生部令第85号).2012-06-07.
5Bolton-Maggs PHB ( Ed), Cohen H on behalf of the Serious Haz- ards of Transfusion (SHOT) Steering Group, The 2011 AnnualSHOT Report (2012) . 2012.06-22 [ 2013-06-04 ], http:// www. shotuk, org/wp-eontent/ uploads/ 2012/07/ SHOT-ANNU- AL-REPORT_FinalWebVersionBookmked_2012 06 22. pd.
6Serious Hazards of Transfuison. Definition of current SHOT catego- ries & What to report ( revised, 2012 ). 2013-01-02 [ 2013-06-04 ] http ://www. shotuk, org/wp-content/uploads/2013/01/SHOT- defin!tions-NovO 12 -final. pdf.
8LaP ar DJ,Crosby IK,Ailawadi GA,et al.Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery.J Thorac Cardiovasc Surg,2013,145(3):796-803.
9Hung M,Besser M,Sharples LD,et al.The prevalence and association with transfusion,intensive care unit stay and mortality of preoperative anaemia in a cohort of cardiac surgery patients.Anaesthesia,2011,66(9):812-818.
10Horvath KA,Acker MA,Chang H,et al.Blood transfusion and infection after cardiac surgery.Ann Thorac Surg,2013,95(6):2194-2201.
